Mometason ADGC nasal spray

Mometason ADGC is a glucocorticoid-based nasal spray used primarily for the treatment of hay fever and allergic rhinitis symptoms. The 'ADGC' brand is part of a strategic pharmaceutical line in Germany focusing on cost-effective, high-quality generic medications.

The brand is owned by Zentiva, a significant player in the European pharmaceutical market. Zentiva itself has undergone various ownership changes, previously being part of Sanofi before being acquired by Advent International, a global private equity firm. Production typically takes place in specialized pharmaceutical facilities across Europe, with a major hub in Germany and the Czech Republic to supply the DACH region markets.